India
· Delayed Price · Currency is INR Krebs Biochemicals & Industries Company Description
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India.
The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.
The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications.
In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies.
The company was incorporated in 1991 and is based in Visakhapatnam, India.
| Country | India |
| Founded | 1991 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 191 |
| CEO | Jitendra Shah |
Contact Details
Address: Kothapalli Village Visakhapatnam, 531031 India | |
| Phone | 91 91 2114 4984 |
| Website | krebsbiochem.com |
Stock Details
| Ticker Symbol | KREBSBIO |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE268B01013 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jitendra Rameshchandra Shah | MD, Chief Executive Officer and Director |
| Ritesh Jain | Chief Financial Officer |
| Rakesh R. Kalbate | Company Secretary and Compliance Officer |